MeSH tree: D20.215.894.865
As COVID-19 becomes endemic, an important group of people who continue to require vaccination is future birth cohorts of children. Yet, in the face of everchanging variants, as well as the waning of antibodies with time after ...
Apr 30, 2024
0
39
A row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday over patents for COVID vaccine technology that helped save millions of lives during the pandemic.
Apr 23, 2024
0
72
In Brazil, researchers at the University of São Paulo (USP) and the Pernambuco division of Oswaldo Cruz Foundation (FIOCRUZ) are developing a Zika vaccine. The formulation was tested on mice and found to be efficacious, inducing ...
Apr 18, 2024
0
48
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
80
As we age, the immune system's efficacy weakens, leading to less effective defenses against new pathogens—such as the SARS-CoV-2 virus. How immunosenescence in older adults affects their immune response to COVID-19 mRNA vaccinations ...
Apr 3, 2024
0
48
Adults with certain socio-demographic and clinical characteristics may have weaker antibody responses to COVID-19 vaccination, which could leader to a higher risk of infection, according to a recent study published in Nature ...
Mar 22, 2024
0
100
mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19). These vaccines work by triggering ...
Mar 8, 2024
0
50
Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen have examined a man who has received more than 200 vaccinations against COVID-19. They learned of his case via newspaper ...
Mar 5, 2024
0
220
The success of mRNA vaccines against COVID-19 has unleashed a flood of interest in using the technology to create more vaccines and treatments for everything from rare diseases and infections to cancer.
Feb 28, 2024
0
61
A research team at Freie Universität Berlin has conducted a comprehensive comparison of the efficacy of a mucosal, replication-competent but fully attenuated virus vaccine, sCPD9-ΔFCS, with the monovalent mRNA vaccine BNT162b2 ...
Feb 27, 2024
0
49
